Litcius/Paper detail

Alpha-lipoic acid treatment improves adverse cardiac remodelling in the diabetic heart – The role of cardiac hydrogen sulfide-synthesizing enzymes

George J. Dugbartey, Quinsker L. Wonje, Karl K. Alornyo, Ismaila Adams, Deborah E. Diaba

2022Biochemical Pharmacology21 citationsDOIOpen Access PDF

Abstract

Alpha-lipoic acid (ALA) is a licensed drug for the treatment of diabetic neuropathy. We recently reported that it also improves diabetic cardiomyopathy (DCM) in type 2 diabetes mellitus (T2DM). In this study, we present evidence supporting our hypothesis that the cardioprotective effect of ALA is via upregulation of cardiac hydrogen sulfide (H2S)-synthesizing enzymes. Following 12 h of overnight fasting, T2DM was induced in 23 out of 30 male Sprague-Dawley rats by intraperitoneal administration of nicotinamide (110 mg/kg) followed by streptozotocin (55 mg/kg) while the rest served as healthy control (HC). T2DM rats then received either oral administration of ALA (60 mg/kg/day; n = 7) or 40 mg/kg/day DL-propargylglycine (PAG, an endogenous H2S inhibitor; n = 7) intraperitoneally for 6 weeks after which all rats were sacrificed and samples collected for analysis. Untreated T2DM rats served as diabetic control (DCM; n = 9). T2DM resulted in weight loss, islet destruction, reduced pancreatic β-cell function and hyperglycemia. Histologically, DCM rats showed significant myocardial damage evidenced by myocardial degeneration, cardiomyocyte vacuolation and apoptosis, cardiac fibrosis and inflammation, which positively correlated with elevated levels of cardiac damage markers compared to HC rats (p < 0.001). These pathological alterations worsened significantly in PAG-treated rats (p < 0.05). However, ALA treatment restored normoinsulemia, normoglycemia, prevented DCM, and improved lipid and antioxidant status. Mechanistically, ALA significantly upregulated the expression of cardiac H2S-synthesizing enzymes and increased plasma H2S concentration compared to DCM rats (p < 0.001). ALA preserves myocardial integrity in T2DM likely by maintaining the expression of cardiac H2S-synthezing enzymes and increasing plasma H2S level.

Topics & Concepts

Diabetic cardiomyopathyMedicineInternal medicineEndocrinologyStreptozotocinDiabetes mellitusCardiac function curveCardiac fibrosisDownregulation and upregulationType 2 Diabetes MellitusIntraperitoneal injectionHeart failureCardiomyopathyChemistryBiochemistryGeneBiochemical Acid Research StudiesSulfur Compounds in BiologyBiochemical effects in animals